$3.03
0.37% today
Nasdaq, Sep 03, 06:35 pm CET
ISIN
US7163821066
Symbol
PETS

PetMed Express, Inc. Stock price

$3.02
-0.18 5.63% 1M
-1.20 28.44% 6M
-1.80 37.34% YTD
-0.17 5.33% 1Y
-17.67 85.40% 3Y
-31.08 91.14% 5Y
-13.52 81.74% 10Y
-6.58 68.53% 20Y
Nasdaq, Closing price Tue, Sep 02 2025
-0.05 1.63%

Key metrics

Basic
Market capitalization
$62.4m
Enterprise Value
$12.3m
Net debt
positive
Cash
$50.1m
Shares outstanding
20.7m
Valuation (TTM | estimate)
P/E
302.0 | negative
P/S
0.3 | 0.3
EV/Sales
0.1 | 0.1
EV/FCF
14.3
P/B
0.7
Dividends
DPS
$1.20
Yield 1Y | 5Y
39.7% | 4.2%
Growth 1Y | 5Y
0.0% | 7.1%
Payout 1Y | 3Y
12,000.0% | 137.0%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$247.0m | $236.4m
EBITDA
$8.4m | $3.5m
EBIT
$1.5m | $3.8m
Net Income
$360.0k | $-5.1m
Free Cash Flow
$860.0k
Growth (TTM | estimate)
Revenue
-10.8% | -15.9%
EBITDA
227.0% | 413.8%
EBIT
111.9% | 147.2%
Net Income
104.4% | 32.2%
Free Cash Flow
-50.0%
Margin (TTM | estimate)
Gross
27.7%
EBITDA
3.4% | 1.5%
EBIT
0.6%
Net
0.1% | -2.1%
Free Cash Flow
0.4%
Financial Health
Equity Ratio
56.9%
Return on Equity
-7.7%
ROCE
1.6%
ROIC
0.3%
Debt/Equity
0.0
More
EPS
$0.0
FCF per Share
$0.0
Short interest
9.6%
Employees
287
Rev per Employee
$980.0k
Show more

Is PetMed Express, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

PetMed Express, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a PetMed Express, Inc. forecast:

2x Hold
33%
4x Sell
67%

Analyst Opinions

6 Analysts have issued a PetMed Express, Inc. forecast:

Hold
33%
Sell
67%

Financial data from PetMed Express, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
247 247
11% 11%
100%
- Direct Costs 179 179
10% 10%
72%
68 68
12% 12%
28%
- Selling and Administrative Expenses 60 60
29% 29%
24%
- Research and Development Expense - -
-
-
8.38 8.38
227% 227%
3%
- Depreciation and Amortization 6.86 6.86
12% 12%
3%
EBIT (Operating Income) EBIT 1.52 1.52
112% 112%
1%
Net Profit 0.36 0.36
104% 104%
0%

In millions USD.

Don't miss a Thing! We will send you all news about PetMed Express, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PetMed Express, Inc. Stock News

Neutral
GlobeNewsWire
15 days ago
Investors can contact the law firm at no cost to learn more about recovering their losses
Neutral
GlobeNewsWire
16 days ago
Block & Leviton LLP is investigating PetMed Express (NASDAQ: PETS) for securities fraud. Investors who have lost money in PetMeds should contact the firm.
Neutral
GlobeNewsWire
22 days ago
DELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced that its Chief Executive Officer, Sandra Campos, and Chief Financial Officer, Robyn D'Elia, have resigned from their positions and employment with the Company.
More PetMed Express, Inc. News

Company Profile

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

Head office United States
CEO Sandra Campos
Employees 287
Founded 1996
Website www.1800petmeds.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today